Dis-Chem Pharmacies (JSE:DCP) COGS-to-Revenue : 0.78 (As of Aug. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Dis-Chem Pharmacies COGS-to-Revenue?

Dis-Chem Pharmacies's Cost of Goods Sold for the six months ended in Aug. 2023 was R13,876 Mil. Its Revenue for the six months ended in Aug. 2023 was R17,856 Mil.

Dis-Chem Pharmacies's COGS to Revenue for the six months ended in Aug. 2023 was 0.78.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Dis-Chem Pharmacies's Gross Margin % for the six months ended in Aug. 2023 was 22.29%.

Dis-Chem Pharmacies COGS-to-Revenue Historical Data

The historical data trend for Dis-Chem Pharmacies's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dis-Chem Pharmacies COGS-to-Revenue Chart

Dis-Chem Pharmacies Annual Data

Trend

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

COGS-to-Revenue

Get a 7-Day Free Trial

0.76

0.77

0.78

0.77

Dis-Chem Pharmacies Semi-Annual Data
	Feb14	Feb15	Aug15	Feb16	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23
COGS-to-Revenue	Get a 7-Day Free Trial														0.78	0.77	0.77	0.77	0.78

Dis-Chem Pharmacies COGS-to-Revenue Calculation

Dis-Chem Pharmacies's COGS to Revenue for the fiscal year that ended in Feb. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	25076.217	/	32663.513
	=	0.77

Dis-Chem Pharmacies's COGS to Revenue for the quarter that ended in Aug. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	13876.296	/	17855.999
	=	0.78

Dis-Chem Pharmacies (JSE:DCP) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Dis-Chem Pharmacies's Gross Margin % for the six months ended in Aug. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	13876.296 / 17855.999
	=	22.29 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Dis-Chem Pharmacies COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Dis-Chem Pharmacies's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Dis-Chem Pharmacies (JSE:DCP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dis-Chem Pharmacies Ltd (JSE:DCP) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685

Website

https://www.dischem.co.za

Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries its business operations principally in South Africa.